LOTUSEYE.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 02:56):

Stats
Today's Volume	16 875.00
Average Volume	324 572
Market Cap	1.29B
EPS	INR0 ( 2024-02-15 )
Next earnings date	( INR0 ) 2024-05-21
Last Dividend	INR0.500 ( 2023-09-18 )
Next Dividend	INR0 ( N/A )
P/E	36.41
ATR14	INR0.399 (0.64%)

Volume Correlation

Long: 0.21 (neutral)

Short: 0.60 (weak)

Signal:(53.026) Neutral

Lotus Eye Hospital and Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lotus Eye Hospital and Correlation - Currency/Commodity

0.00
( neutral )

0.07
( neutral )

-0.07
( neutral )

0.05
( neutral )

0.03
( neutral )

Lotus Eye Hospital and Financials

Annual	2022
Revenue:	INR470.44M
Gross Profit:	INR250.59M (53.27 %)
EPS:	INR1.960

FY	2022
Revenue:	INR470.44M
Gross Profit:	INR250.59M (53.27 %)
EPS:	INR1.960

FY	2022
Revenue:	INR380.86M
Gross Profit:	INR192.62M (50.58 %)
EPS:	INR1.440

FY	2021
Revenue:	INR316.67M
Gross Profit:	INR160.14M (50.57 %)
EPS:	INR0.751

Financial Reports:

No articles found.

Lotus Eye Hospital and Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Lotus Eye Hospital and Dividend Information - Dividend Junior

Dividend Sustainability Score: 2.78 - low (50.00%) | Divividend Growth Potential Score: 3.91 - Decrease likely (21.71%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.500	2017-08-02
Last Dividend	INR0.500	2023-09-18
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR2.50	--
Avg. Dividend % Per Year	0.55%	--
Score	1.47	--
Div. Sustainability Score	2.78
Div.Growth Potential Score	3.91
Div. Directional Score	3.35	--

Next Divdend (Est)
(2025-02-04)

INR0.506 Estimate 2.90 %

Dividend Stability

0.23 Very Poor

Dividend Score

1.47

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	INR0	0.00%
2018	INR0.500	1.72%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0.500	1.45%
2022	INR0.500	0.95%
2023	INR0.500	0.62%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SESHAPAPER.NS	Dividend Knight	2023-06-07	Annually	23	1.14%
MANAKCOAT.NS	Dividend Junior	2023-08-22	Sporadic	4	0.09%
GOODYEAR.NS	Dividend Knight	2023-07-26	Annually	5	4.02%
AVANTIFEED.NS	Dividend Junior	2023-08-03	Annually	14	0.86%
TRIL.NS	Dividend Junior	2023-07-27	Sporadic	17	0.22%
PILANIINVS.NS	Dividend Junior	2023-08-29	Annually	13	0.56%
JKCEMENT.NS	Dividend Junior	2023-08-01	Annually	19	0.37%
DEVIT.NS	Dividend Junior	2023-09-22	Annually	8	0.28%
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0730	1.500	8.54	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0608	1.500	-0.435	-0.653	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	51.85	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.26	2.00	8.91	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.26	2.00	8.37	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.451	1.000	5.81	5.81	[0.2 - 0.8]
operatingProfitMarginTTM	0.0909	1.000	-0.182	-0.182	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				2.78

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	36.21	1.000	6.44	0	[1 - 100]
returnOnEquityTTM	0.0608	2.50	-0.280	-0.653	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.26	2.00	8.91	10.00	[0 - 30]
dividendYielPercentageTTM	0.812	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.26	2.00	8.91	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0608	1.500	-3.74	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.140	1.000	9.01	0	[0.1 - 0.5]
Total Score				3.91

Lotus Eye Hospital and

Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.